| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.09▲ | 3.10▲ | 3.11▲ | 3.13▲ | 3.06▲ |
| MA10 | 3.10▲ | 3.11▲ | 3.11▲ | 3.05▲ | 2.74▲ |
| MA20 | 2.98▲ | 2.95▲ | 2.96▲ | 3.02▲ | 2.51▲ |
| MA50 | 2.96▲ | 3.01▲ | 3.02▲ | 2.63▲ | 2.97▲ |
| MA100 | 2.93▲ | 2.77▲ | 2.67▲ | 2.48▲ | 3.40▼ |
| MA200 | 2.60▲ | 2.56▲ | 2.48▲ | 2.99▲ | 4.01▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.019▲ | 0.029▲ | 0.023▲ | 0.008▲ | 0.132▲ |
| RSI | 64.832▲ | 62.038▲ | 60.925▲ | 61.794▲ | 56.096▲ |
| STOCH | 54.896 | 76.789 | 76.789 | 78.505 | 73.378 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -4.688▲ | -15.972▲ |
| CCI | 165.008▲ | 100.093▲ | 100.915▲ | 108.284▲ | 117.593▲ |
|
Thursday, March 12, 2026 10:02 PM
FRAMINGHAM, MA / ACCESS Newswire / March 13, 2026 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
|
|
Thursday, December 11, 2025 02:00 PM
FRAMINGHAM, MA / ACCESS Newswire / December 11, 2025 / Xenetic Biosciences, Inc. (XBIO) (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/04/26 | 3.18 | 3.267 | 3.15 | 3.26 | 13,339 |
| 13/04/26 | 3.04 | 3.11 | 2.99 | 3.11 | 12,174 |
| 10/04/26 | 3.06 | 3.1847 | 3.0584 | 3.06 | 23,050 |
| 09/04/26 | 3.08 | 3.15 | 3.06 | 3.15 | 12,530 |
| 08/04/26 | 3.29 | 3.29 | 3.05 | 3.05 | 28,829 |
| 07/04/26 | 3.10 | 3.20 | 2.9901 | 3.20 | 26,970 |
| 06/04/26 | 3.1187 | 3.19 | 2.9794 | 3.155 | 12,469 |
| 02/04/26 | 2.79 | 3.08 | 2.70 | 3.01 | 12,269 |
| 01/04/26 | 2.79 | 2.88 | 2.7416 | 2.82 | 7,040 |
| 31/03/26 | 2.72 | 2.79 | 2.66 | 2.68 | 8,315 |
|
|
||||
|
|
||||
|
|